The latest data, presented at VIVA and The VEINS

The 2022 Late-Breaking Clinical Trial submission portal is now closed. To be added to our mailing list and receive future updates, please email

We are pleased to announce that The VEINS 2022 will offer a venous-focused series of Late-Breaking Clinical Trials in addition to the late-breaking presentation series at VIVA.


Physicians and researchers will present groundbreaking findings from late-breaking clinical trials, follow-up data from major randomized trials and registries, and first-in-man experiences with novel devices or drugs.

A limited number of abstracts will be accepted for presentation. Accepted late-breaking clinical trials will be presented on Monday, October 31 (The VEINS) and Tuesday-Wednesday, November 1-2 (VIVA). Each presentation will be followed by a discussion and Q&A with a panel of expert faculty.

Abstracts will be evaluated and scored based on the following criteria:

  • Interest to field
  • Research methods
  • Quality of data
  • Primary endpoint presented

Notification of acceptance or rejection will be sent the week of August 22, 2022. Subsequent communication will provide specifics about submitting the presentation and the date and time of the presentation.

If you have questions please contact Brita Thorne via e-mail:

Embargo Policy

VIVA embargoes Late-Breaking Clinical Trial information from becoming public until after the commencement of the session as listed in the conference program or on No publication, exhibitor, or affiliated company may disseminate information until after the commencement of the Late-Breaking Clinical Trial session in which it is presented.

Submissions for future conferences

To be added to our mailing list and receive future updates, please email